Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVO | LLY | JNJ | ABBV | MRK |
| Company | Novo Nordisk A/S ADR | Eli Lilly and Company | Johnson & Johnson | Abbvie Inc | Merck & Company |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 107.75 | 777.86 | 143.84 | 170.58 | 99.90 |
| High | 108.99 | 788.00 | 146.66 | 176.50 | 100.80 |
| Low | 107.73 | 772.43 | 143.71 | 170.21 | 99.36 |
| Last | 108.01 | 778.62 | 146.41 | 175.38 | 100.06 |
| Change | -0.04 | -0.38 | +2.56 | +3.75 | unch |
| % Change | -0.04% | -0.05% | +1.78% | +2.18% | unch |
| Volume | 5,415,400 | 3,924,700 | 10,342,899 | 7,664,700 | 13,975,000 |
| 20-Day Average Volume | 5,220,575 | 3,700,965 | 8,527,140 | 6,333,795 | 13,561,360 |
| Previous Close | 108.05 | 779.00 | 143.85 | 171.63 | 100.06 |
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 107.46 | 786.63 | 151.13 | 175.97 | 100.95 |
| 20-Day Raw Stochastic | 60.37% | 49.39% | 21.26% | 56.63% | 48.94% |
| 20-Day Relative Strength | 46.22% | 41.97% | 34.43% | 43.66% | 43.95% |
| Weighted Alpha | -5.72 | +19.73 | -8.24 | +6.79 | -14.91 |
| Today's Opinion | 80% Sell | 88% Sell | 56% Sell | 56% Sell | 100% Sell |
| Previous Opinion | 80% Sell | 88% Sell | 56% Sell | 56% Sell | 100% Sell |
| Last Month's Opinion | 100% Sell | 40% Sell | 24% Sell | 8% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.08% since 12/10/24 | -2.62% since 12/10/24 | -1.89% since 12/10/24 | -0.17% since 12/10/24 | -0.93% since 12/10/24 |
| Low | 104.14 on 12/13/24 | 772.43 on 12/17/24 | 143.52 on 12/16/24 | 170.21 on 12/17/24 | 99.26 on 12/11/24 |
| High | 112.52 on 12/11/24 | 801.84 on 12/12/24 | 148.50 on 12/11/24 | 176.50 on 12/17/24 | 103.00 on 12/12/24 |
| 1-Month | |||||
| %Chg | +6.16% since 11/15/24 | +4.34% since 11/15/24 | -4.93% since 11/15/24 | +6.30% since 11/15/24 | +3.89% since 11/15/24 |
| Low | 99.42 on 11/18/24 | 711.40 on 11/18/24 | 143.52 on 12/16/24 | 163.81 on 11/19/24 | 95.26 on 11/19/24 |
| High | 112.52 on 12/11/24 | 846.46 on 12/04/24 | 157.12 on 11/22/24 | 184.24 on 11/27/24 | 105.07 on 12/09/24 |
| 3-Month | |||||
| %Chg | -18.17% since 09/17/24 | -14.08% since 09/17/24 | -12.37% since 09/17/24 | -9.34% since 09/17/24 | -15.41% since 09/17/24 |
| Low | 99.42 on 11/18/24 | 711.40 on 11/18/24 | 143.52 on 12/16/24 | 163.81 on 11/19/24 | 94.48 on 11/15/24 |
| High | 135.20 on 09/19/24 | 939.86 on 09/20/24 | 168.35 on 09/18/24 | 207.32 on 10/31/24 | 119.38 on 09/18/24 |
| 6-Month | |||||
| %Chg | -23.05% since 06/17/24 | -12.02% since 06/17/24 | +0.32% since 06/17/24 | +3.36% since 06/17/24 | -21.52% since 06/17/24 |
| Low | 99.42 on 11/18/24 | 711.40 on 11/18/24 | 143.52 on 12/16/24 | 163.52 on 07/03/24 | 94.48 on 11/15/24 |
| High | 148.15 on 06/25/24 | 972.53 on 08/22/24 | 168.85 on 09/04/24 | 207.32 on 10/31/24 | 134.63 on 06/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 484,698,368 | 739,156,416 | 352,500,096 | 309,921,024 | 253,115,280 |
| Shares Outstanding, K | 4,487,532 | 949,316 | 2,407,623 | 1,767,140 | 2,529,635 |
| Annual Sales | 33,724,300,000 | 34,124,100,000 | 85,159,000,000 | 54,318,000,000 | 60,115,000,000 |
| Annual Net Income | 12,150,770,000 | 5,240,400,000 | 35,153,000,000 | 4,863,000,000 | 365,000,000 |
| Last Quarter Sales | 10,511,240,000 | 11,439,100,000 | 22,471,000,000 | 14,460,000,000 | 16,657,000,000 |
| Last Quarter Net Income | 4,024,170,000 | 970,300,000 | 2,694,000,000 | 1,561,000,000 | 3,157,000,000 |
| 60-Month Beta | 0.40 | 0.41 | 0.51 | 0.58 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.90 on 11/06/24 | 1.18 on 10/30/24 | 2.42 on 10/15/24 | 3.00 on 10/30/24 | 1.57 on 10/31/24 |
| Latest Earnings Date | 01/29/25 | 02/04/25 | 01/22/25 | 02/07/25 | 02/04/25 |
| Most Recent Dividend | 0.362 on 08/16/24 | 1.300 on 11/15/24 | 1.240 on 11/26/24 | 1.550 on 10/15/24 | 0.810 on 12/16/24 |
| Next Ex-Dividends Date | 08/16/24 | 02/14/25 | 11/26/24 | 01/15/25 | 12/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 34.97 | 76.60 | 14.05 | 15.97 | 16.82 |